The role of the mitochondria in mediating cytotoxicity of anti-cancer therapies

Journal of Bioenergetics and Biomembranes

Volumn 39, Issue 1, 2007, Pages 13-21

  Nguyen, Dao M ^a   Hussain, Mustafa ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apo2L TRAIL; Apoptosis; Bcl2 superfamily; Cancer; Caspase; Chemotherapy; Mitochondria

Indexed keywords

CISPLATIN; DEATH RECEPTOR 4; DEATH RECEPTOR 5; FAS ASSOCIATED DEATH DOMAIN PROTEIN; HISTONE DEACETYLASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PACLITAXEL; PROTEIN P75; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTINEOPLASTIC ACTIVITY; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL DISRUPTION; CELL STRESS; CYTOTOXICITY; DNA ADDUCT; HUMAN; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; OLIGOMERIZATION; SHORT SURVEY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL DEATH; HUMANS; MITOCHONDRIA; NEOPLASMS; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 34249941116     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-006-9055-9     Document Type: Short Survey

References (130)

1. Almasan A, Ashkenazi A (2003) Cytokine Growth Factor Rev 14:337-348
2. Andre N, Carre M, Brasseur G, et al (2002) FEBS Lett 532:256-260
3. Arizono Y, Yoshikawa H, Naganuma, et al (2003) Br J Cancer 88:298-306
4. Ashkenazi A, Dixit VM (1999) Curr Opin Cell Biol 11:255-260
5. Ashkenazi A, Pai RC, Fong S, et al (1999) J Clin Invest 104:155-162
6. Bacus SS, Gudkov AV, Lowe M, et al (2001) Oncogene 20:147-155
7. Bauer JA, Trask DK, Kumar B, et al (2005) Mol Cancer Ther 4:1096-1104
8. Boatright KM, Renatus M, Scott FL, et al (2003) Mol Cell 11:529-541
9. Brichese L, Cazettes G, Valette A (2004) Cell Cycle 3:1312-1319
10. Brown JM, Wilson G (2003) Cancer Biol Ther 2:477-490
11. Certo M, Del GMV, Nishino M, et al (2006) Cancer Cell 9:351-365
12. Cheng EH, Sheiko TV, Fisher JK, et al (2003) Science 301:513-517
13. Cheng EH, Wei MC, Weiler S, et al (2001) Mol Cell 8:705-711
14. Chipuk JE, Bouchier-Hayes L, Kuwana T, et al (2005) Science 309:1732-1735
15. Chipuk JE, Kuwana T, Bouchier-Hayes L, et al (2004) Science 303:1010-1014
16. Chopin V, Slomianny C, Hondermarck H, et al (2004) Exp Cell Res 298:560-573
17. Del Bello B, Valentini MA, Zunino F, et al (2001) Oncogene 20:4591-4595
18. Demarcq C, Bunch RT, Creswell D, Eastman A (1994) Cell Growth Differ 5:983-993
19. Devarajan P, Savoca M, Castaneda MP, et al (2002) Hear Res 174:45-54
20. Doi S, Soda H, Oka M, et al (2004) Mol Cancer Ther 3:1397-1402
21. Du C, Fang M, Li Y, et al (2000) Cell 102:33-42
22. Du Y, Yin F, Liu C, et al (2006) Biochem Biophys Res Commun 345:1092-1098
23. Duckett CS, Nava VE, Gedrich RW, et al (1996) EMBO J 15:2685-2694
24. Dunant A, Pignon JP, Le Chevalier T (2005) Adjuvant chemotherapy for non-small cell lung cancer: contribution of the International Adjuvant Lung Trial. Clin Cancer Res 11:5017s-5021s
25. Dzamitika S, Salerno M, Pereira-Maia E, et al (2006). J Bioenerg Biomembr 38:11-21
26. Eliopoulos AG, Kerr DJ, Herod J, et al (1995) Oncogene 11:1217-1228
27. Evdokiou A, Bouralexis S, Atkins GJ, et al (2002) Int J Cancer 99:491-504
28. Fantin VR, Leder P (2006) Oncogene 25:4787-4797
29. Fox SA, Kusmiaty, Loh SS, Dharmarajan AM, Garlepp MJ (2005) Biochem Biophys Res Commun 337:983-991
30. Fulda S, Debatin KM (2005) Eur J Cancer 41:786-798
31. Fulda S, Debatin KM (2006) Oncogene 25:4798-4811
32. Fulda S, Meyer E, Debatin KM (2002) Oncogene 21:2283-2294
33. Galluzzi L, Larochette N, Zamzami N, Kroemer G (2006) Oncogene 25:4812-4830
34. Garcia-Morales P, Gomez-Martinez A, Carrato A, et al (2005) Mol Cancer Ther 4:1222-1230
35. Green DR, Kroemer G (2004) Science 305:626-629
36. Guo F, Sigua C, Tao J, Bali P, et al (2004) Cancer Res 64:2580-2589
37. Hao JH, Yu M, Liu FT, et al (2004) Cancer Res 64:3607-3616
38. Henderson C, Mizzau M, Paroni G, et al (2003) J Biol Chem 278:12579-12589
39. Hengartner MO (2000) Nature 407:770-776
40. Hopkins-Donaldson S, Belyanskaya LL, Simoes-Wust AP, et al (2006) Neoplasia 8:551-559
41. Huisman C, Ferreira CG, Broker LE, et al (2002) Clin Cancer Res 8:596-606
42. Ibrado AM, Huang Y, Fang G, Bhalla K (1996) Cell Growth Differ 7:1087-1094
43. Ihrlund LS, Hernlund E, Viktorsson K, et al (2006) Exp Cell Res 312:1581-1589
44. Inoue S, MacFarlane M, Harper N, et al (2004) Cell Death Differ 11 Suppl 2:S193-S206
45. Jaboin J, Wild J, Hamidi H, Khanna C, et al (2002) Cancer Res 62:6108-6115
46. Jiang M, Wei Q, Wang J, Du Q, et al (2006) Oncogene 25:4056-4066
47. Johnson JR, Bross P, Cohen M, et al (2003) Clin Cancer Res 9:1972-1979
48. Jordan MA, Toso RJ, Thrower D, Wilson L (1993) Proc Natl Acad Sci USA 90:9552-9556
49. Kelley SK, Ashkenazi A (2004) Curr Opin Pharmacol 4:333-339
50. Kelley SK, Harris LA, Xie D, et al (2001) J Pharmacol Exp Ther 299:31-38
51. Kelly WK, Richon VM, O'Connor O, et al (2003) Clin Cancer Res 9:3578-3588
52. Kim YH, Park JW, Lee JY, Kwon TK (2004) Carcinogenesis 25:1813-1820
53. Kondo K, Yamasaki S, Sugie T, et al (2005) Int J Cancer
54. Konishi A, Shimizu S, Hirota J, et al (2003) Cell% 19 114:673-688
55. Korsmeyer SJ, Wei MC, Saito M, et al (2000) Cell Death Differ 7:1166-1173
56. Kroemer G, Dallaporta B, Resche-Rigon M (1998) Annu Rev Physiol 60:619-642
57. Kuwana T, Bouchier-Hayes L, Chipuk JE, et al (2005) Mol Cell 17:525-535
58. Lacour S, Micheau O, Hammann AD, et al (2003) Oncogene 22:1807-1816
59. Lasfer M, Davenne L, Vadrot N, et al (2006) FEBS Lett 580:2547-2552
60. LeBlanc H, Lawrence D, Varfolomeev E, et al (2002) Nat Med 8:274-281
61. LeBlanc HN, Ashkenazi A (2003) Cell Death Differ 10:66-75
62. Letai A (2005) J Clin Invest 115:2648-2655
63. Li R, Moudgil T, Ross HJ, Hu HM (2005) Cell Death Differ 12:292-303
64. Liang BC, Ullyatt E (1998) Cell Death Differ 5:694-701
65. Liu W, Bodle E, Chen JY, et al (2001) Am J Respir Cell Mol Biol 25:111-118
66. Lucas DM, Davis ME, Parthun MR, et al (2004) Leukemia 18:1207-1214
67. Marks PA, Jiang X (2005) Cell Cycle 4
68. Maxhimer JB, Reddy RM, Zuo J, et al (2005) J Thorac Cardiovasc Surg 129:53-63
69. McEleny KR, Watson RW, Fitzpatrick JM (2001) Prostate Cancer Prostatic Dis 4:28-32
70. Mihara M, Erster S, Zaika A, et al (2003) Mol Cell 11:577-590
71. Muhlethaler-Mottet A, Bourloud KB, Auderset K, et al (2004) Oncogene 23:5415-5425
72. Nakata S, Yoshida T, Horinaka M, et al (2004) Oncogene 23:6261-6271
73. Ng CP, Bonavida B (2002) Mol Cancer Ther 1:1051-1058
74. Ng CP, Zisman A, Bonavida B (2002) Prostate 53:286-299
75. Nguyen DM, Schrump WD, Chen GA, et al (2004) Clin Cancer Res 10:1813-1825
76. Nguyen DM, Schrump WD, Tsai WS, et al (2003) J Thorac Cardiovasc Surg 125:1132-1142
77. Nguyen DM, Yeow WS, Ziauddin MF, et al (2006) T Cancer J 12:257-273
78. Nicholson DW (1999) Cell Death Differ 6:1028-1042
79. Nishikawa M, Nagatomi H, Nishijima M, et al (2001) Cancer Lett 171:133-138
80. Oda E, Ohki R, Murasawa H, et al (2000) Science 288:1053-1058
81. Oliver CL, Bauer JA, Wolter KG, et al (2004) Clin Cancer Res 10:7757-7763
82. Oliver CL, Miranda MB, Shangary S, et al (2005) Mol Cancer Ther 4:23-31
83. Oltersdorf T, Elmore SW, Shoemaker AR, et al (2005) Nature 435:677-681
84. Ozoren N, el Deiry WS (2002) Neoplasia 4:551-557
85. Piekarz R, Bates S (2004) Curr Pharm Des 10:2289-2298
86. Pukac L, Kanakaraj P, Humphreys R, et al (2005) Br J Cancer 92:1430-1441
87. Reed JC, Pellecchia M (2005) Blood 106:408-418
88. Rosato RR, Grant S (2004) Expert Opin Investig Drugs 13:21-38
89. Rishindra MR, Yeow WS, Ziauddin MF, et al (2007) Apoptosis 12:55-71
90. Ruefli AA, Ausserlechner MJ, Bernhard D, et al (2001) Proc Natl Acad Sci USA 98: 10833-10838
91. Ruffolo SC, Breckenridge DG, Nguyen M, et al (2000) Cell Death Differ 7:1101-1108
92. Ruvolo PP, Deng X, May WS (2001) P Leukemia 15:515-522
93. Saelens X, Festjens N, Vande WL, et al (2004) Oncogene 23:2861-2874
94. Salvesen GS, Dixit VM (1999) C Proc Natl Acad Sci USA 96:10964-10967
95. Sax JK, Fei P, Murphy ME, Bernhard E, et al (2002) Nat Cell Biol 4:842-849
96. Sayers TJ, Brooks AD, Koh CY, et al (2003) Blood 102:303-310
97. Scaffidi C, Fulda S, Srinivasan A, et al (1998) EMBO J 17:1675-1687
98. Schrump, DS and Nguyen, DM (2005) Semin Oncol 92:257-61
99. Schrump DS, Nguyen DM, Kunst TE, et al (2002) Clin Lung Cancer 4:186-192
100. Scorrano L, Korsmeyer SJ (2003) Biochem Biophys Res Commun 304:437-444
101. Shankar S, Srivastava RK (2004) Drug Resist Updat 7:139-156
102. Shao Y, Gao Z, Marks PA, Jiang X (2004) Proc Natl Acad Sci USA 101:18030-18035
103. Shepherd FA, Rodrigues PJ, Ciuleanu T, et al (2005) N Engl J Med 353:123-132
104. Siddik ZH (2003) Oncogene 22:7265-7279
105. Singh TR, Shankar S, Srivastava RK (2005) Oncogene
106. Soderling TR (1999) Trends Biochem Sci 24:232-236
107. Srivastava RK, Srivastava AR, Korsmeyer SJ, et al (1998) Mol Cell Biol 18:3509-3517
108. Stathopoulos GP, Katis C, Tsavdaridis D, et al (2006) Cancer Chemother Pharmacol 58:555-560
109. Sunters A, Fernandez dM, Stahl M, et al (2003) J Biol Chem 278:49795-49805
110. Tan TT, Degenhardt K, Nelson DA, et al (2005) Cancer Cell 7:227-238
111. Thomadaki H, Talieri M, Scorilas A (2006) Biol Chem 387:1081-1086
112. Tirro E, Consoli ML, Massimino M, et al (2006) Cancer Res 66:4263-4272
113. Tsao MS, Sakurada A, Cutz JC, et al (2005) N Engl J Med 353:133-144
114. van Loo G, Saelens X, van Gurp M, et al (2002) Cell Death Differ 9:1031-1042
115. Vanoosten RL, Moore JM, Ludwig AT, Griffith TS (2005) Mol Ther 11:542-552
116. Varbiro G, Veres B, Gallyas F Jr, Sumegi B (2001) Free Radic Biol Med 31:548-558
117. Verhagen AM, Ekert PG, Pakusch M, et al (2000) Cell 102:43-53
118. Xu L, Yang D, Wang ST, et al (2005) Mol Cancer Ther 4:197-205
119. Yagita H, Takeda K, Hayakawa Y, et al (2004) T Cancer Sci 95:777-783
120. Yang Z, Schumaker LM, Egorin MJ, et al (2006) Clin Cancer Res 12:5817-5825
121. Yeh PY, Chuang SE, Yeh KH, et al (2002) Biochem Pharmacol 63:1423-1430
122. Yeow WS, Ziauddin MF, Maxhimer JB, et al (2006) Br J Cancer 94:1436-1445
123. Yeow WS, Baras A, Chua A, et al (2006). Journal of Thorac Cardiovasc Surgery 132:1356-62
124. Yu J, Zhang L, Hwang PM, Kinzler KW, Vogelstein B (2001) Mol Cell 7:673-682
125. Yu X, Guo ZS, Marcu MG, Neckers L, et al (2002) J Natl Cancer Inst 94:504-513
126. Zhai D, Jin C, Satterthwait AC, Reed JC (2006) Cell Death Differ 13:1419-1421
127. Zhang L, Fang B (2005) Cancer Gene Ther 12:228-237
128. Zhou Q, Fukushima P, DeGraff W, et al (2000) Cancer Res 60:2611-2615
129. Zhu H, Guo W, Zhang L, Davis JJ, et al (2005) Cancer Biol Ther 4:393-397
130. Ziauddin MF, Yeow WS, Maxhimer JB, et al (2006) Neoplasia 8:446-457